184 related articles for article (PubMed ID: 25015681)
1. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.
Al Badarin FJ; Wimmer AP; Kennedy KF; Jacobson AF; Bateman TM
J Nucl Cardiol; 2014 Aug; 21(4):756-62; quiz 753-55, 763-5. PubMed ID: 25015681
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiac
De Vincentis G; Frantellizzi V; Fedele F; Farcomeni A; Scarparo P; Salvi N; Fegatelli DA; Mancone M; Verschure DO; Verberne HJ
J Nucl Cardiol; 2019 Aug; 26(4):1188-1196. PubMed ID: 29594915
[TBL] [Abstract][Full Text] [Related]
3. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
[TBL] [Abstract][Full Text] [Related]
4. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
[TBL] [Abstract][Full Text] [Related]
5. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
Hachamovitch R; Nutter B; Menon V; Cerqueira MD
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
[TBL] [Abstract][Full Text] [Related]
6. Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study.
Giovanni S; Stefano M; Teresa SM; Margherita C; Giovanni B; Umberto P; Paola P; Giacomo C; Pierfranco D; Alfonso G; Riccardo C; Claudio M
J Nucl Cardiol; 2020 Oct; 27(5):1787-1797. PubMed ID: 30377997
[TBL] [Abstract][Full Text] [Related]
7. A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.
Verschure DO; Poel E; Travin MI; Henzlova MJ; Jain D; Jacobson AF; Verberne HJ
Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1201-1209. PubMed ID: 34427293
[TBL] [Abstract][Full Text] [Related]
8. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
[TBL] [Abstract][Full Text] [Related]
9. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
[TBL] [Abstract][Full Text] [Related]
10. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.
Sood N; Al Badarin F; Parker M; Pullatt R; Jacobson AF; Bateman TM; Heller GV
J Nucl Cardiol; 2013 Oct; 20(5):813-20. PubMed ID: 23864400
[TBL] [Abstract][Full Text] [Related]
11. Cardiac
Verschure DO; de Groot JR; Mirzaei S; Gheysens O; Nakajima K; van Eck-Smit BLF; Aernout Somsen G; Verberne HJ
Int J Cardiol; 2017 Dec; 248():403-408. PubMed ID: 28847545
[TBL] [Abstract][Full Text] [Related]
12. Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
Ikeda-Yorifuji I; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Fukuhara E; Abe M; Nakamura J; Fukunami M
J Nucl Cardiol; 2020 Jun; 27(3):992-1001. PubMed ID: 30761485
[TBL] [Abstract][Full Text] [Related]
13. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
[TBL] [Abstract][Full Text] [Related]
14. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
[TBL] [Abstract][Full Text] [Related]
16. Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
Nakajima K; Nakata T
J Nucl Med; 2015 Jun; 56 Suppl 4():11S-19S. PubMed ID: 26033897
[TBL] [Abstract][Full Text] [Related]
17. ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study.
Narula J; Gerson M; Thomas GS; Cerqueira MD; Jacobson AF
J Nucl Med; 2015 Jul; 56(7):1011-8. PubMed ID: 26069309
[TBL] [Abstract][Full Text] [Related]
18. Prognostic usefulness of planar
Agostini D; Ananthasubramaniam K; Chandna H; Friberg L; Hudnut A; Koren M; Miyamoto MI; Senior R; Shah M; Travin MI; Dahl JV; Chen K; Levy WC;
J Nucl Cardiol; 2021 Aug; 28(4):1490-1503. PubMed ID: 31468379
[TBL] [Abstract][Full Text] [Related]
19. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
Marshall A; Cheetham A; George RS; Mason M; Kelion AD
Heart; 2012 Sep; 98(18):1359-65. PubMed ID: 22904144
[TBL] [Abstract][Full Text] [Related]
20. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
